How AI/ML and advanced techniques are enhancing clinical development: Lessons learned from use in study design, patient and site ID, safety, and risk-based monitoring

Register free: http://www.appliedclinicaltrialsonline.com/act_w/results

Event Overview:

Clinical trials create vast amounts of disparate data sets, historically generated and retained in silos. Today, integrating, gaining access to and leveraging the breadth of available data requires advanced technologies and innovative approaches. 

Learn how IQVIA is using artificial intelligence (AI) and machine learning (ML) with advanced and predictive analytics to transform clinical development. IQVIA will share examples of AI/ML and analytics in use today, and cite benefits being generated. Use cases and lessons learned include:

• Study design

• Site ID & patient population identification

• Safety automation 

• Clinical monitoring/risk-based monitoring

Register today and hear how companies are realizing the benefits of AI/ML and advanced techniques to work in their trials – today!

Key Learning Objectives:

Using AI/ML and advanced techniques in clinical development is more than just hype – it is greatly enhancing clinical trials today!

Learn how pharmaceutical firms are realizing the benefits of AI/ML and advanced techniques in their trials with better study design, faster site and patient identification, enhanced and automated safety approaches and more informed, faster decision-making with risk-based and centralized monitoring.

Speakers: Lucas Glass, Global Head of Analytics Center of Excellence, R&D, IQVIA

Gary Shorter, Head of Artificial Intelligence, IQVIA

Rajneesh Patil, Head of Process Design & Analytics, Centralized Monitoring, Services, IQVIA

Time and date: Tuesday, Oct. 1, 2019 at 11am EDT

On demand available after airing until Oct. 1, 2020.

Sponsor: IQVIA

Register free: http://www.appliedclinicaltrialsonline.com/act_w/results